fda warning letters glp-1 compounders october 2025 Beyond the Headlines: to FDA Achieves Year 1 Goals – CDER Warning Letters Jump 50%

Recalls & Warnings December 15, 2022 Beware of Supplements, Homeopathic Products Promoted to Treat Flu, Says FDA On December 13, 2022, the FDA warned consumers to beware of supplements and homeopathic products, as well as nasal sprays, sanitizers and other products that promise to prevent or treat the flu

For Egrifta specifically, the approved prescribing information states the reconstituted product should be used promptly

Our IGF-1 LR3 Peptide is stored and handled according to industry guidelines to ensure stability

In more recent years, data have been published on efficacy, safety, neonatal, and maternal outcomes on the use of metformin in pregnancy

Hair growth support needs 3-6 months minimum

Some practitioners use the Z-track method (pulling tissue aside before injection) to prevent leakage